Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching

Manuscript Number: 

22-0361R1

Author(s): 
Albert Amran, Avram S. Bukhbinder, Ryan Coburn, Omar Hasan, Xiaoqian Jiang, Yejin Kim, Yaobin Ling, Kamal N. Phelps, Srivathsan Ramesh, Rosemarie E. Schmandt, Paul E. Schulz, Qian Xiao

Disclosures

Albert Amran

  • Nothing to Disclose

Avram S. Bukhbinder

  • Nothing to Disclose

Ryan Coburn

  • Nothing to Disclose

Omar Hasan

  • Nothing to Disclose

Xiaoqian Jiang

  • Nothing to Disclose

Yejin Kim

  • Nothing to Disclose

Yaobin Ling

  • Nothing to Disclose

Kamal N. Phelps

  • Nothing to Disclose

Srivathsan Ramesh

  • Nothing to Disclose

Rosemarie E. Schmandt

  • Nothing to Disclose

Paul E. Schulz

  • Consulting Fees:
    Occasional advisory panels for Lilly, Acadia, and Biogen.
    Lecture Fees:
    Occasional disease state education talks for Lilly, Acadia, and Biogen.
    Patents/Royalties
    I serve as an expert witness for medical malpractice cases and other types of cases. None related to this paper. Not sure where to put this, but i am on about 12 NIH grants, none related to this study. And i have about 12 treatment trials funded by many pharmaceutical companies, including Lilly, Acadia, Biogen, Roche, UCB, etc. None are related to this paper, in my opinion.

Qian Xiao

  • Nothing to Disclose